1. Home
  2. TRVG vs PLX Comparison

TRVG vs PLX Comparison

Compare TRVG & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$2.93

Market Cap

214.1M

Sector

Technology

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.90

Market Cap

230.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVG
PLX
Founded
2005
1993
Country
Germany
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
214.1M
230.0M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
TRVG
PLX
Price
$2.93
$2.90
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$4.09
$12.00
AVG Volume (30 Days)
81.6K
1.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$53,399,000.00
Revenue This Year
$15.59
$9.67
Revenue Next Year
$8.42
$23.86
P/E Ratio
$16.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.71
$1.34
52 Week High
$5.83
$3.19

Technical Indicators

Market Signals
Indicator
TRVG
PLX
Relative Strength Index (RSI) 51.58 59.08
Support Level $2.79 $1.39
Resistance Level $2.96 $3.03
Average True Range (ATR) 0.10 0.15
MACD -0.00 -0.03
Stochastic Oscillator 46.48 49.09

Price Performance

Historical Comparison
TRVG
PLX

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and All other countries.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

Share on Social Networks: